Orofacial pain and its association with various disorders

1. INTRODUCTION

Public health is seriously affected by pain, and there is research that suggests that more than 80% of people may experience pain at some point in their lifetimes that is severe enough to need the utilization of medical resources. This conclusion is in line with studies that have shown that painful sensations are among the most frequent triggers for seeking medical attention. [1] Some of the most frequent and incapacitating pain in the head and neck area is caused by structures that the trigeminal system innervates. The head, face, masticatory muscles, temporomandibular joint, and related structures are among these structures.

Disorders of orofacial discomfort are highly frequent and may be incapacitating. They pose a challenge to clinicians because the orofacial region is complex and pain can come from a variety of sources. [2] Clinicians must have a thorough understanding of the pain conditions that result from the structures of the face, and it is strongly advised that they adopt a multidisciplinary approach to the treatment of orofacial pain disorders. [3], [4] divides the classification of orofacial pain (OFP) into two groups: situations that are physically related (Axis 1) and situations that are psychologically related (Axis 2).

Physical conditions include neuropathic pains, which include episodic (such as trigeminal neuralgia [TN]) and continuous (such as peripheral/centralized mediated) pains; temporo-mandibular disorders (TMD), which include disorders of the temporomandibular joint (TMJ) and disorders of the musculoskeletal structures (for example, masticatory muscles and the cervical spine); and neurovascular disorders (such as migraine). Psychological issues include, for example, mood and anxiety disorders.

OFP

OFP is a term that is frequently used to describe pain that affects the head, face, oral cavity, and neck. [5] The term has been defined as "a frequent form of pain perceived in the face and/or the oral cavity." [6] Anatomically, OFP is described as pain that occurs primarily or exclusively under the orbitomeatal line, anterior to the pinnae, and above the neck. OFP can be primary or secondary, with primary causing localized pain and secondary originating elsewhere, such as in the cervical or brain tissues. Due, in part, to the diversity of the numerous organ structures and the intricacy of the innervations they include, patients who appear with problems that are assumed to be OFP may have a broad range of presentations and diagnoses.

One of the biggest challenges to understanding the nature and nosology of OFP has been the absence of standardized diagnostic criteria and the disparate terminology employed by the many organizations whose main focus is the research of pain. The most frequent causes of orofacial pain, such as burning mouth syndrome, persistent idiopathic facial pain, atypical odontalgia, pain-related temporomandibular disorder (TMD), and trigeminal neuralgia, are briefly discussed in this article.

Understanding the Physiology of Orofacial Pain

The orofacial region is made up of the oral cavity, which includes the gingiva and oral mucosa, the face, the jaw bone, and the temporomandibular joint. [7] Primary afferent neurons, pathologic changes in the trigeminal ganglion, brainstem nociceptive neurons, and higher brain function that controls orofacial nociception are all components of the physiology of the OFP pathways.

The Various Forms of Orofacial and Facial Pain

Acute orofacial pain is defined as the sudden onset of pain that is related to physical sensations and may be of limited duration as well as being temporary due to tissue injury causes. Acute and chronic orofacial pain are classifications of orofacial pain that are concerned with durations. [8] They can be further divided into nociceptive, inflammatory, and neuropathic pain. [9]. Orofacial pain is regarded as chronic if it persists for more than three months, which is the typical period of time for the body to heal from an injury. The three forms of pain nociceptive, inflammatory, and neuropathic that are most likely to have contributed to or contributed to orofacial pain can also be classified.

The sort of pain that is triggered by noxious stimuli directly stimulating nociceptive sensory neurons is referred to as "nociceptive pain" Extremes of temperature, powerful mechanical forces, and chemical irritants are some examples of these unpleasant stimuli. The central nervous system will then receive signals from the nociceptors, which will eventually cause a pain reaction like the withdrawal reflex. Inflammatory pain is a discomfort that is brought on by injured tissues. Inflammatory mediators are produced into the body when tissues are injured, and this eventually causes the pain perception system to become active. Neuropathic pain is a type of pain that results from issues with either the peripheral or central nervous system.

Burning Mouth Syndrome, Often Known as BMS

When there is clinically healthy oral mucosa present, BMS is characterized by a burning sensation or discomfort that affects the mouth. BMS can be brought on by a variety of causes. Although BMS most frequently affects the tongue, it can also infect other areas of the oral cavity. As an alternative, patients may experience taste disruption, xerostomia, or tingling or numbing feelings. [10] Scala et al. [11] have noted that 'primary' BMS develops when organic reasons for oral burning are unavailable. However, "secondary" BMS might emerge from either a local or a systemic infection. Between 0.7 and 15% of people are thought to have BMS. Between five and ten times as many females as men are affected by BMS (although the precise ratio varies between these two amounts).

The reported research provides evidence that the BMS peaks between the fifth and seventh decades. BMS is a chronic condition that, in the majority of instances, only sometimes enters remission over the course of several years. BMS has a variety of underlying causes, and the combination of local, systemic, and psychological factors is thought to have played a significant role in its emergence. A significant percentage of BMS may also be related to neuropathic changes that come from perimenopausal hormone dysregulation, according to an ingenious idea put out by Woda and colleagues. Additionally, a research conducted by Lauria and colleagues found that, in comparison to the control group, tongue biopsies collected from BMS patients exhibited a lower density of epithelial nerve fibers. Burning mouth syndrome (BMS) is a type of persistent neuropathic pain that can have a significant and negative impact on a person's quality of life. Lamey and colleagues' research suggests that people with BMS may exhibit a greater incidence of negative early life events as well as chronic fatigue. Numerous studies have shown that patients with BMS have a poorer quality of life than those in control groups.

In order to treat BMS, patients must be reassured, given hope, information about their illness, and assistance in managing it independently. Researchers Bonathan and colleagues demonstrated that educating patients about the problems associated with chronic facial pain and doing it in a compassionate way might make patients feel less helpless in the face of their illness. Patients with BMS should be encouraged to develop self-management strategies that include exercising, unwinding, and finding other things to occupy their time.

Antidepressant medication has been suggested as a potential therapy for BMS due to the association between BMS and mental health issues including depression and anxiety. However, there is not enough evidence to either endorse or disapprove the use of antidepressants in the management of BMS. There have also been reports of findings that are equivalent when it comes to the use of benzodiazepines and anticonvulsants like gabapentin. It has been demonstrated that BMS patients who engage in psychological treatments like cognitive behavioral therapy (CBT) see a reduction in the intensity of their pain. A multimodal approach with a focus on self-management and medical and psychological therapy may be effective in minimizing the negative psychosocial consequences of BMS and improving quality of life. [10]

Pifp, or Persistent Idiopathic Facial Pain, is an Abbreviation.

Persistent idiopathic facial pain (PIFP), also known as atypical facial pain, is defined by the International Classification of Headache Disorders (ICHD) [12] as "persistent facial and/or oral pain, with varying presentations, but recurring daily for more than 2 hours per day over more than 3 months, in the absence of clinical neurological deficit." PIFP typically manifests unilaterally and may initially be limited to one side of the face, typically affecting the maxilla.

Patients with PIFP may be more likely to experience mental co-morbidities such depression and obsessive-compulsive behaviors. These symptoms may have progressed in a chronic manner and may have existed prior to the commencement of PIFP. The treatment of PIFP depends on the early detection of the condition and patient education. [13] This strategy is extremely important since invasive surgeries may cause traumatic neuropathy and a worsening of symptoms.

Odontalgia Atypical (AO)

AO has been mentioned as one of the subforms of PIFP. However, because AO can appear following a traumatic experience, it is also feasible to categorize it as a painful form of post-traumatic trigeminal neuropathy. It is believed that AO is indicated by dull, continuous pain that either affects the teeth or most frequently manifests at the site of a recent dental extraction. Despite the lack of clinical or radiological manifestations, these symptoms are nonetheless present. Patients may have various symptoms following dental care, according to observations.

The discomfort persists even after having dental treatments, including an extraction, and it could even extend to the teeth close to the impacted tooth. It's probable that AO affects younger people, and the prevalence of the ailment varies less between men and women. Neuropathic pain is thought to be the primary cause of the pathophysiology of AO.

In a research by Baad-Hansen and colleagues, it was shown that individuals with AO showed anomalies in their intraoral somatosensory function. When compared to healthy controls, the researchers found that individuals with AO frequently displayed hypersensitivity to intraoral stimulation. Early identification and patient education are essential for the successful management of AO. Get a correct diagnosis of AO as soon as you can to prevent needless and unnecessary dental and surgical procedures. Treatment for AO is, for the most part, similar to that for other neuropathic illnesses that cause face discomfort. In a similar vein, AO may also be linked to high levels of melancholy and worry; as a result, in some circumstances, psychological counseling may be required in addition to medical care. [13]

Aches and Pains Associated with TMD

TMDs are a collective term for diseases that affect the temporomandibular joint (TMJ) and/or the muscles that govern chewing. TMJ and masticatory muscle discomfort, pain that is triggered by function, pain that is not associated with another pain diagnosis, pain that is responsive to palpation, and pain that includes these structures are all characteristics of pain-related TMD. A TMD can be identified after thoroughly analyzing the patient's medical history and doing a physical examination. During the clinical examination, the temporomandibular joint and the muscles of mastication should be palpated, and joint noises should be heard.

Additionally, it has been suggested that psychological testing is required due to the potential effects of chronic TMD on quality of life and the emergence of chronic pain-related disability. This is the situation because a psychological evaluation is necessary because to the potential effects of chronic TMD. According to estimates, TMD will affect up to one-third of people at some time in their life. TMD is one of the three conditions that most commonly cause persistent pain, according to the most recent study. Back discomfort and headaches round out the other two. It has been noted that women are more likely to have TMD than males, and that the 20–30 age range is when the condition is most common. Furthermore, temporomandibular joint disease (TMD) can be either temporary or persistent. Temporomandibular joint dysfunction (TMD) is a common condition with a known cause, such as prolonged dental care.

The symptoms of acute TMD are usually transient and go away on their own. About 20% of persons with TMD have chronic temporomandibular joint dysfunction, which is characterized by discomfort that has persisted for longer than three months. If these symptoms go untreated for a long time, they may lead to depression as well as chronic pain-related disability. TMD is caused by a complex interplay between a variety of distinct anatomical, physiological, and psychological factors, which is referred to as multifactorial etiology. TMD may develop for a number of causes, including central and peripheral sensitization pathways, according to certain theories. In the great majority of instances, TMD patients may be properly recognized and treated in a basic care setting. On the other hand, patients who initially come with chronic TMD, significant psychosocial risk factors, and other co-morbidities associated with chronic pain may profit from an early referral to secondary treatment.

The initial course of treatment should place a strong emphasis on educating the patient about TMD in order to encourage the development of self-management techniques. These self-management practices also include physical workouts and relaxation methods like yoga. It has been shown that these treatments can help people with a variety of chronic pain conditions that affect the musculoskeletal system, such as fibromyalgia. One study found that teaching patients about their condition is essential to promoting selfmanagement of temporomandibular joint dysfunction (TMD), and that this approach is preferable to using splints. Physiotherapy, which relaxes muscles while improving function, can have a similar impact. By aiding in the development of strategies to manage the discomfort related to the illness, psychological therapies like cognitive behavioral therapy may also be beneficial in facilitating self-management of TMD.

When acute TMD exacerbations occur, simple analgesia, such as a non-steroidal anti-inflammatory drug (NSAID), can be a helpful treatment. Similar to this, benzodiazepines may be used to treat acute TMD that is accompanied with restricted opening, however it is advised that only a short course of medication be given because of the risk of dependency. Tricyclic antidepressants (TCAs), such as amitriptyline and nortriptyline, may be useful in the therapy of chronic TMD that is refractory to conventional therapeutic approaches, even in people who do not have depression. The use of occlusal splints in the treatment of TMD has grown in popularity. The benefits of splint therapy have, however, been theorized to be due to the placebo effect, and it has also been suggested that splint therapy may result in hypervigilance and the growth of parafunction.

As a result, splint therapy shouldn't be used exclusively; rather, it should be considered alongside a number of other self-management strategies. There is no evidence to back up the use of occlusal adjustment as a therapeutic method for persistent TMD. Botulinum toxin type A, popularly referred to as Botox, has also been used to treat TMD that won't go away. However, there is a lack of information on the effectiveness of botox in treating the pain brought on by TMD. Additionally, a randomised controlled study's findings revealed no discernible difference between the efficacy of botox and a placebo in the treatment of TMD-related pain.

The initial line of defense in the fight against TMD-related pain is often conservative treatment strategies like those covered above. Surgery may be an option for patients with disc displacement or degenerative joint disease who also have pain and functional problems and who do not respond to conservative therapy. These people could benefit from surgical treatments.

In patients with chronic TMD who do not have significant functional impairment, surgical treatments should be avoided because it is unlikely that these therapies would result in benefits and may even exacerbate symptoms. In certain individuals, minimally invasive procedures like arthrocentesis may be used to enhance symptoms and function. Alternately, you can think about arthroscopy, which has the benefit of fiberoptic guidance for lavage of the joint space. These two techniques serve as substitutes for arthroscopic surgery. Only patients with severe stages of degenerative illness may choose TMJ replacement surgery. [14], [15] Nervosa trigeminalis (TN)

This condition is a kind of neuropathy that has the potential to harm one or more branches of the trigeminal nerve. The pain is localized to one side of the body, begins quickly, lasts for a brief period of time, and ends abruptly. It has been said that the agony is frequently excruciating and is comparable to getting stabbed or electric shock. It can happen on its own or be triggered by extremely mild triggers like being touched, consuming food, or being exposed to wind. [16] The two kinds of this illness that were initially recognized were classical TN and symptomatic TN. The superior cerebellar pontine artery is most usually the site of neuroavascular compression in classical TN, which is what gives it its name. The only difference between symptomatic TN and classical TN is that the latter is brought on by structural lesions rather than vascular compression.

Multiple sclerosis (MS) and space-occupying lesions are a few of instances of these structural lesions. The term "idiopathic" TN refers to the third diagnostic category for TN that has recently been added. This kind of TN manifests itself when neither compression nor pathology can be identified. The ability to do daily tasks and the state of one's health may both be negatively impacted by TN, which may also have a significant impact on quality of life. The capacity for social interaction may also be significantly impacted by TN. The results of some research suggest that patients may experience social isolation as a result of the severity of their pain, a job loss, depression, or concern. The diagnosis of TN is almost completely based on the patient's medical history as there are no objective examinations or tests that may confirm the diagnosis. In order to rule out the existence of any dental pathology, dental radiographs should also be taken as part of a thorough dental examination. MRI can also demonstrate whether the trigeminal nerve is neurovascularly compressed in the posterior cranial fossa.

A study that concentrated on primary care found that there are 27 cases of TN for every 100,000 persons. According to research, females are more likely to develop the condition than males of any age group, with the peak occurrence happening between the ages of 45 and 59. How far the illness could proceed in TN is mostly uncertain. There is a common misconception that the pain associated with TN gradually grows worse over time and that medications eventually lose their efficacy. However, a recent study of classical TN patients who were receiving medication contradicted this notion. Some reports claim that the pathophysiology of TN might be linked to a neuropathic origin. Devor et al. presented the "ignition theory."

[17] According to this theory, injury to the trigeminal axons in the nerve root or ganglion causes the development of trigeminal neuralgia (TN). Vascular compression of the nerve at the root entry zone is the most frequent cause of this injury. The consequences lead to the development of hyperexcitable neurones. These neurons engage in a characteristic behavior known as "after discharge," in which they carry on excitably even when an external stimulus is no longer present. This "after discharge" activates the nearby neurones, which results in pain that resembles an electric shock. The influx of potassium leads the neuron to become resistant to additional stimulation, resulting in the following hyper-polarization of the neuron, known as the refractory phase.

The "gold standard" medication for TN is carbamazepine, which is used as the main form of therapy. The second-line drug is oxcarbazepine, which is generally thought to have fewer side effects and potential drug interactions than carbamazepine. [18] Research is currently being done on the use of the selective sodium channel blocker BIIB07494 as a novel TN therapy.

Due to BIIB074's selective activity on peripheral neuro receptors, it is hypothesized that TN patients who use it may have less pain relief and fewer side effects than those who use currently available anticonvulsants that are centrally active. Receiving local anesthetic blocks into trigger sites may be helpful for patients who have recently started taking systemic medication and are experiencing an acute exacerbation of TN. While the patient waits for the oral medications to work, these injections provide analgesia for a shorter length of time. Even if the great majority of TN patients get pharmaceutical treatment, there is still a chance that the medical therapy for TN may be unsuccessful owing to insufficient pharmacological efficacy or unfavorable side effects.

Surgery may potentially be an option in the treatment of TN; however, a research by Gronseth et al.19 found that there is not enough information to determine when surgery should be offered. People may elect surgery over medications, according to the findings of a research that looked at the decision-making processes of patients receiving therapy for TN.

Each of the three groups peripheral, Gasserian ganglion level, and posterior fosa root entry zone relates to a distinct location and can be used to categorize the surgical treatment of TN. The longest-lasting pain relief is thought to be provided by microvascular decompression. [18], [19] the difficulties in treating TN patients include delayed diagnosis, drug-related side effects, and a dearth of psychological support. Historically, TN has been treated using a very biological strategy that includes using medications and surgical methods. Additionally, it has been shown that patients may get advantages from taking part in TN- specific patient support groups.

2. DISCUSSION

With a frequency of 25% or more, OFP is very common overall. It is widely known that exposure to OFP causes a significant decline in quality of life and an increase in the severity of impairment levels. The second most frequent cause of OFP, primary HA that manifests in the facial area, is followed by common ear, nose, and throat disorders, dental ailments, and pain-related TMD (with a prevalence of 10-15% in adults). It is noteworthy to note that because the trigeminocervical system has a role in the pathophysiology of CGH, it is quite likely to appear unilaterally in the face area.

The results of various epidemiological studies have shown that female sex is a risk factor for feeling pain in the body, even if it seems that these results depend on the location of the discomfort. However, investigations undertaken by a number of different authors have not demonstrated a substantial difference in the occurrence of uncomfortable symptoms in this area between the sexes. According to some studies, women have more facial pain than men do, while another study found that women experience more jaw joint-related pain than men do. Additionally, studies have shown that pain complaints peak between the ages of 50 and 65 and then decline. [20] However, according to two studies, younger individuals had the highest incidence rates.

This deviates from the conclusions of numerous writers who discovered no sex differences in prevalence across several orofacial pain measurements. Only two studies have examined the prevalence of orofacial pain over a wide range of sites and symptoms. They found that women were far more likely than men to experience toothaches, oral sores, jaw joint pain, face pain, and burning mouth, with rates for jaw joint pain and face discomfort being almost twice as high.

In this study, the researchers discovered that older females were more likely than older males to experience jaw joint pain, face pain, and painful oral sores, whereas older males were more likely to report toothache pain. [1] There is also a substantial body of literature that looks at sex differences in pain ratings. For instance, studies in the field of experimental pain have shown that women are more sensitive to painful stimuli than men are. [21], [22] Research in the field of epidemiology, which is consistent with studies in the field of experimental pain, has also suggested that women may perceive their pain as being more intense than men do. 23 It is becoming more and more concerning that more people are experiencing oral and facial pain. The orofacial region has complex anatomical structures, which makes diagnosis and treatment more challenging for many specialists.

A person's ability to do daily tasks and quality of life can both be significantly harmed by persistent orofacial pain. If one wants to start a treatment plan based on evidence, it is crucial to diagnose the patient quickly and recommend them to secondary care. Orofacial pain problems have a complex etiology that may be addressed through a biopsychosocial approach to pain management, which also lessens the impact these illnesses have on patients' general health and the economy.

Authors Contributions Statement

Name of Authors C M So Va Fo I R D O E Vi Su P Fu

Sonal GP Pillai • • • • • • • • • • • • • • Dr. Lynn Johnson • • • • Dr. Hiroj Bagde • • • • • • •

C : Conceptualization I : Investigation Vi : Visualization M : MethodologyR : ResourcesSu : Supervision So : SoftwareD : Data CurationP : Project Va : ValidationO : Writing - Original Draftadministration Fo : Formal analysisE : Writing - Review & EditingFu : Funding acquisition

Acknowledgment

The authors have no specific acknowledgments to make for this research.

Funding Information

This research received no specific grant from any funding agency in the public, commercial, or notfor-profit sectors.

Conflict of Interest Statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Informed Consent

All participants were informed about the purpose of the study, and their voluntary consent was obtained prior to data collection.

Ethical Approval

The study was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki and approved by the relevant institutional authorities.

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

1. [1] J. L. Riley 3rd and G. H. Gilbert, 'Orofacial pain symptoms: an interaction between age and sex', Pain, vol. 90, no. 3, pp. 245-256, Feb. 2001. doi.org/10.1016/S0304-3959(00)00408-5
2. [2] M. Romero-Reyes and J. M. Uyanik, 'Orofacial pain management: current perspectives', J. Pain Res., vol. 7, pp. 99-115, Feb. 2014. doi.org/10.2147/JPR.S37593
3. [3] J. P. Okeson, Orofacial Pain Clinical Management. Carol Stream, Illinois: Quintessence Publishing Co, Inc, 2005.
4. [4] 'The Classification of Orofacial Pains, Okeson JP. North American Oral Maxillofac Surg Clin', vol. 20, pp. 133-144, 2008. doi.org/10.1016/j.coms.2007.12.009
5. [5] S. D. Bender, 'Orofacial pain and headache: a review and look at the commonalities', Curr. Pain Headache Rep., vol. 18, no. 3, p. 400, Mar. 2014. doi.org/10.1007/s11916-013-0400-5
6. [6] J. Olesen, 'The third edition of the worldwide classification of headache diseases, published by the worldwide Headache Society (IHS)', Cephalalgia, vol. 38, pp. 1-211, 2018.
7. [7] Pain physiology, Messlinger K, Handwerker HO 2015. Pain 29:522-530. doi.org/10.1007/s00482-015-0052-y
8. [8] Review of Literatures: Physiology of Orofacial Pain in Dentistry, Rotpenpian N., Yakkaphan P. eNeuro. Apr 27 2021; 8(2):ENEURO.0535-20.2021. Reference this: 1523/ENEURO.0535-20.2021. PMCID: PMC8086974; PMID: 33820801. https://doi.org/10.1523/ENEURO.0535-20.2021
9. [9] Y. Lee, C. H. Lee, and U. Oh, 'Painful channels in sensory neurons', Mol Cells, vol. 20, pp. 315-324, 2005. doi.org/10.1016/S1016-8478(23)25242-5
10. [10] S. Ghurye and R. McMillan, 'Orofacial pain - an update on diagnosis and management', Br. Dent. J., vol. 223, no. 9, pp. 639-647, Nov. 2017. doi.org/10.1038/sj.bdj.2017.879
11. [11] A. Scala, L. Checchi, M. Montevecchi, I. Marini, and M. A. Giamberardino, 'Update on burning mouth syndrome: overview and patient care', Crit Rev Oral Biol Med, vol. 14, pp. 275-291, 2003. doi.org/10.1177/154411130301400405
12. [12] A. Scala, L. Checchi, M. Montevecchi, I. Marini, and M. A. Giamberardino, 'Update on burning mouth syndrome: overview and patient care', Crit Rev Oral Biol Med, vol. 14, pp. 275-291, 2003. doi.org/10.1177/154411130301400405
13. [13] J. A. V. Durham, S. J. Davies, and S. D. Harrison, The UK Specialist Interest Group in Orofacial Pain and TMDs (USOT) has released an update and management recommendations for primary care on temporomandibular disorders (TMDs). .
14. [14] Recent developments in temporomandibular disorders (TMDs), Durham J, Wassell R. 2011; Chapter Pain; 5: 18. doi.org/10.1177/204946371100500104
15. [15] P. Burden Of Trigeminal Neuralgia Tölle, T. Dukes, and E. Sadosky, 'Results of a Cross-Sectional Survey of Health State Impairment and Treatment Patterns in Six European Countries', Pain Practice, vol. 6, pp. 153-160, 2006. doi.org/10.1111/j.1533-2500.2006.00079.x
16. [16] 'The Patient's Journey Through Trigeminal Neuralgia', Pain Clin Updates, vol. 22, pp. 1-8, 2014.
17. [17] G. Cruccu, G. Gronseth, and J. Alksne, 'Guidelines for the management of trigeminal neuralgia from AAN-EFNS', Eur J Neurol, vol. 15, pp. 1013-1028, 2008. doi.org/10.1111/j.1468-1331.2008.02185.x
18. [18] C. Gronseth and A. Others, 'Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies, practice parameter: the diagnostic diagnosis and treatment of trigeminal neuralgia (an evidence-based review)', vol. 71, pp. 1183-1190, 2008. doi.org/10.1212/01.wnl.0000326598.83183.04
19. [19] J. J. Kerssens, J. Dekker, M. J. Sorbi, and J. M. Bensing, 'A review of the literature on the prevalence of chronic benign pain disease in adults was conducted by Verhaak PF', Pain, vol. 77, no. 3, pp. 231-239, 1998. doi.org/10.1016/S0304-3959(98)00117-1
20. [20] 'Gender variations in the reactions to noxious stimuli', Fillingim RB, Maixner W, vol. 4, pp. 209-221, 1995. doi.org/10.1016/S1082-3174(11)80022-X
21. [21] I. Riley, M. E. Robinson, E. A. Wise, C. D. Myers, and R. B. Fillingim, 'Sex differences in the perception of unpleasant experimental stimuli: a meta-analysis', Pain, vol. 74, pp. 181-187, 1998. doi.org/10.1016/S0304-3959(97)00199-1
22. [22] F. Bosch, M. Campillo, M. Canellas, and J. E. Banos, 'An epidemiological comparison of pain complaints in the general population of Catalonia (Spain) by Bassols A', Pain, vol. 83, no. 1, pp. 9-16, 1999. doi.org/10.1016/S0304-3959(99)00069-X